sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Alpha 1 Antitrypsin Deficiency Treatment Market Insights, Forecast to 2025

Global Alpha 1 Antitrypsin Deficiency Treatment Market Insights, Forecast to 2025

Category : Pharmaceuticals and Healthcare QY Research Pages :122
Published Date : 2018-12-26

 

Severe deficiency of alpha-1 antitrypsin (AAT) can cause early-onset emphysema and several liver diseases, including cirrhosis, neonatal hepatitis and hepatocellular carcinoma. The discovery of the structure and function of the AAT protein and the subsequent isolation and purification thereof have made possible alternative therapies aimed at preventing the progression of related pulmonary diseases (so-called "additional therapies"). The isolation of this gene and the advancement of gene therapy have further increased the possibility of specific treatment. Most specific treatments for AAT deficiency aim to increase plasma AAT levels (and thus elevated AAT concentrations in the interstitial lung) above the protection threshold. Other experimental therapeutic approaches attempt to interfere with the production of abnormal AAT proteins or to inhibit the polymerization of abnormal AAT proteins and to promote the secretion of AAT from hepatocytes. For patients with end-stage lung disease or liver disease, organ transplantation is another treatment option. Currently, the most direct and effective way to increase AAT levels in plasma and interstitial lung is by intravenous infusion of pooled alpha-1 antitrypsin (pAAT). The global Alpha 1 Antitrypsin Deficiency Treatment market is valued at 1190 million US$ in 2018 and will reach 2560 million US$ by the end of 2025, growing at a CAGR of 10.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Alpha 1 Antitrypsin Deficiency Treatment market based on company, product type, end user and key regions. This report studies the global market size of Alpha 1 Antitrypsin Deficiency Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Alpha 1 Antitrypsin Deficiency Treatment in these regions. This research report categorizes the global Alpha 1 Antitrypsin Deficiency Treatment market by top players/brands, region, type and end user. This report also studies the global Alpha 1 Antitrypsin Deficiency Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Pfizer Baxter AstraZeneca Grifols Teva Pharmaceutical Industries Boehringer Ingelheim Kamada Ltd GlaxoSmithKline CSL Behring Shire LFB Biomedicaments Abeona Therapeutics Biogen Applied Genetic Technologies Baxalta Arrowhead Research Corporation ProBioGen Chiesi Pharmaceuticals Curaxys ProMetic Life Sciences Market size by Product Augmentation Therapy Bronchodilators Corticosteroids Oxygen Therapy Market size by End User Hospitals Specialty Clinics Pharmacies Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Alpha 1 Antitrypsin Deficiency Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of Alpha 1 Antitrypsin Deficiency Treatment market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Alpha 1 Antitrypsin Deficiency Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Alpha 1 Antitrypsin Deficiency Treatment submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Alpha 1 Antitrypsin Deficiency Treatment are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Alpha 1 Antitrypsin Deficiency Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 Alpha 1 Antitrypsin Deficiency Treatment Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth Rate by Product 1.4.2 Augmentation Therapy 1.4.3 Bronchodilators 1.4.4 Corticosteroids 1.4.5 Oxygen Therapy 1.5 Market by End User 1.5.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth Rate by End User 1.5.2 Hospitals 1.5.3 Specialty Clinics 1.5.4 Pharmacies 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size 2.1.1 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue 2014-2025 2.1.2 Global Alpha 1 Antitrypsin Deficiency Treatment Sales 2014-2025 2.2 Alpha 1 Antitrypsin Deficiency Treatment Growth Rate by Regions 2.2.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Regions 2.2.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturers 3.1.1 Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturers 3.1.2 Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturers 3.1.3 Global Alpha 1 Antitrypsin Deficiency Treatment Market Concentration Ratio (CR5 and HHI) 3.2 Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturers 3.2.1 Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturers (2014-2019) 3.2.2 Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Manufacturers (2014-2019) 3.3 Alpha 1 Antitrypsin Deficiency Treatment Price by Manufacturers 3.4 Alpha 1 Antitrypsin Deficiency Treatment Manufacturing Base Distribution, Product Types 3.4.1 Alpha 1 Antitrypsin Deficiency Treatment Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Alpha 1 Antitrypsin Deficiency Treatment Product Type 3.4.3 Date of International Manufacturers Enter into Alpha 1 Antitrypsin Deficiency Treatment Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Product 4.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Product 4.3 Alpha 1 Antitrypsin Deficiency Treatment Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Alpha 1 Antitrypsin Deficiency Treatment Breakdown Data by End User 6 North America 6.1 North America Alpha 1 Antitrypsin Deficiency Treatment by Countries 6.1.1 North America Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries 6.1.2 North America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Alpha 1 Antitrypsin Deficiency Treatment by Product 6.3 North America Alpha 1 Antitrypsin Deficiency Treatment by End User 7 Europe 7.1 Europe Alpha 1 Antitrypsin Deficiency Treatment by Countries 7.1.1 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries 7.1.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Alpha 1 Antitrypsin Deficiency Treatment by Product 7.3 Europe Alpha 1 Antitrypsin Deficiency Treatment by End User 8 Asia Pacific 8.1 Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment by Countries 8.1.1 Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries 8.1.2 Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment by Product 8.3 Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment by End User 9 Central & South America 9.1 Central & South America Alpha 1 Antitrypsin Deficiency Treatment by Countries 9.1.1 Central & South America Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries 9.1.2 Central & South America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Alpha 1 Antitrypsin Deficiency Treatment by Product 9.3 Central & South America Alpha 1 Antitrypsin Deficiency Treatment by End User 10 Middle East and Africa 10.1 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment by Countries 10.1.1 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries 10.1.2 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment by Product 10.3 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment by End User 11 Company Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Company Business Overview 11.1.3 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Products Offered 11.1.5 Pfizer Recent Development 11.2 Baxter 11.2.1 Baxter Company Details 11.2.2 Company Business Overview 11.2.3 Baxter Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Baxter Alpha 1 Antitrypsin Deficiency Treatment Products Offered 11.2.5 Baxter Recent Development 11.3 AstraZeneca 11.3.1 AstraZeneca Company Details 11.3.2 Company Business Overview 11.3.AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Gross Margin (2014-2019) 11.3.4 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Products Offered 11.3.5 AstraZeneca Recent Development 11.4 Grifols 11.4.1 Grifols Company Details 11.4.2 Company Business Overview 11.4.3 Grifols Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Grifols Alpha 1 Antitrypsin Deficiency Treatment Products Offered 11.4.5 Grifols Recent Development 11.5 Teva Pharmaceutical Industries 11.5.1 Teva Pharmaceutical Industries Company Details 11.5.2 Company Business Overview 11.5.3 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Products Offered 11.5.5 Teva Pharmaceutical Industries Recent Development 11.6 Boehringer Ingelheim 11.6.1 Boehringer Ingelheim Company Details 11.6.2 Company Business Overview 11.6.3 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Products Offered 11.6.5 Boehringer Ingelheim Recent Development 11.7 Kamada Ltd 11.7.1 Kamada Ltd Company Details 11.7.2 Company Business Overview 11.7.3 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Products Offered 11.7.5 Kamada Ltd Recent Development 11.8 GlaxoSmithKline 11.8.1 GlaxoSmithKline Company Details 11.8.2 Company Business Overview 11.8.3 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Gross Margin (2014-2019) 11.8.4 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Products Offered 11.8.5 GlaxoSmithKline Recent Development 11.9 CSL Behring 11.9.1 CSL Behring Company Details 11.9.2 Company Business Overview 11.9.3 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Gross Margin (2014-2019) 11.9.4 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Products Offered 11.9.5 CSL Behring Recent Development 11.10 Shire 11.10.1 Shire Company Details 11.10.2 Company Business Overview 11.10.3 Shire Alpha 1 Antitrypsin Deficiency Treatment Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Shire Alpha 1 Antitrypsin Deficiency Treatment Products Offered 11.10.5 Shire Recent Development 11.11 LFB Biomedicaments 11.12 Abeona Therapeutics 11.13 Biogen 11.14 Applied Genetic Technologies 11.15 Baxalta 11.16 Arrowhead Research Corporation 11.17 ProBioGen 11.18 Chiesi Pharmaceuticals 11.19 Curaxys 11.20 ProMetic Life Sciences 12 Future Forecast 12.1 Alpha 1 Antitrypsin Deficiency Treatment Market Forecast by Regions 12.1.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Regions 2019-2025 12.1.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Forecast by Regions 2019-2025 12.2 Alpha 1 Antitrypsin Deficiency Treatment Market Forecast by Product 12.2.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Product 2019-2025 12.2.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Forecast by Product 2019-2025 12.3 Alpha 1 Antitrypsin Deficiency Treatment Market Forecast by End User 12.4 North America Alpha 1 Antitrypsin Deficiency Treatment Forecast 12.5 Europe Alpha 1 Antitrypsin Deficiency Treatment Forecast 12.6 Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Forecast 12.7 Central & South America Alpha 1 Antitrypsin Deficiency Treatment Forecast 12.8 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Alpha 1 Antitrypsin Deficiency Treatment Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

Get Free Sample

List of Tables and Figures Figure Alpha 1 Antitrypsin Deficiency Treatment Product Picture Table Alpha 1 Antitrypsin Deficiency Treatment Market Segments Table Key Manufacturers Alpha 1 Antitrypsin Deficiency Treatment Covered Table Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Product 2014-2025 Figure Augmentation Therapy Product Picture Table Major Manufacturers of Augmentation Therapy Figure Bronchodilators Product Picture Table Major Manufacturers of Bronchodilators Figure Corticosteroids Product Picture Table Major Manufacturers of Corticosteroids Figure Oxygen Therapy Product Picture Table Major Manufacturers of Oxygen Therapy Table Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth Rate by End User 2019-2025 (K Units) Figure Hospitals Figure Specialty Clinics Figure Pharmacies Figure Alpha 1 Antitrypsin Deficiency Treatment Report Years Considered Figure Global Alpha 1 Antitrypsin Deficiency Treatment Market Size 2014-2025 (Million US$) Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales 2014-2025 (K Units) Table Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Regions 2014-2019 (K Units) Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Regions 2014-2019 Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Regions 2014-2019 Figure 2018 Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Regions Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Regions 2014-2019 (Million US$) Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Regions 2014-2019 Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Regions 2014-2019 Figure 2018 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Regions Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturers (2014-2019) (K Units) Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Manufacturers (2014-2019) Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturers (2014-2019) (Million USD) Table Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Manufacturers (2014-2019) Figure Alpha 1 Antitrypsin Deficiency Treatment Value Share by Manufacturers in 2018 Table Key Manufacturers Alpha 1 Antitrypsin Deficiency Treatment Price (2014-2019) (USD/Unit) Table Alpha 1 Antitrypsin Deficiency Treatment Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Alpha 1 Antitrypsin Deficiency Treatment Product Type Table Date of International Manufacturers Enter into Alpha 1 Antitrypsin Deficiency Treatment Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Product (2014-2019) (K Units) Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Product (2014-2019) Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Product (2014-2019) Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Product in 2018 Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Product (2014-2019) (Million US$) Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Product (2014-2019) Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Product (2014-2019) Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Product in 2018 Table Alpha 1 Antitrypsin Deficiency Treatment Price by Product 2014-2019 (USD/Unit) Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by End User (2014-2019) (K Units) Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Share by End User (2014-2019) Figure Global Sales Alpha 1 Antitrypsin Deficiency Treatment Market Share by End User (2014-2019) Figure Global Sales Alpha 1 Antitrypsin Deficiency Treatment Market Share by End User in 2018 Figure North America Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate 2014-2019 (K Units) Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate 2014-2019 (Million US$) Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2014-2019) (K Units) Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2014-2019) Figure 2018 North America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2014-2019) (Million US$) Table North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries (2014-2019) Figure 2018 North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries Figure United States Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure United States Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (K Units) Figure Canada Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Canada Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Mexico Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales by Product (2014-2019) (K Units) Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Product (2014-2019) Figure 2018 North America Alpha 1 Antitrypsin Deficiency Treatment Market Share by Product Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales by End User (2014-2019) (K Units) Table North America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by End User (2014-2019) Figure 2018 North America Alpha 1 Antitrypsin Deficiency Treatment Market Share by End User Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate 2014-2019 (K Units) Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate 2014-2019 (Million US$) Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2014-2019) (K Units) Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2014-2019) Figure 2018 Europe Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries Table Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2014-2019) (Million US$) Table Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries Figure Germany Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Germany Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure France Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure France Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure UK Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure UK Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Italy Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Russia Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales by Product (2014-2019) (K Units) Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Product (2014-2019) Figure 2018 Europe Alpha 1 Antitrypsin Deficiency Treatment Market Share by Product Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales by End User (2014-2019) (K Units) Table Europe Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by End User (2014-2019) Figure 2018 Europe Alpha 1 Antitrypsin Deficiency Treatment Market Share by End User Figure Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2014-2019) (K Units) Table Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries Table Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries Figure China Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure China Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Korea Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure India Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure India Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Australia Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Philippines Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Thailand Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Singapore Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales by Product (2014-2019) (K Units) Table Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Market Share by Product Table Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales by End User (2014-2019) (K Units) Table Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Market Share by End User Figure Central & South America Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2014-2019) (K Units) Table Central & South America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries Table Central & South America Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2014-2019) (Million US$) Table Central & South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries Figure Brazil Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Brazil Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Argentina Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Alpha 1 Antitrypsin Deficiency Treatment Sales by Product (2014-2019) (K Units) Table Central & South America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Alpha 1 Antitrypsin Deficiency Treatment Market Share by Product Table Central & South America Alpha 1 Antitrypsin Deficiency Treatment Sales by End User (2014-2019) (K Units) Table Central & South America Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Alpha 1 Antitrypsin Deficiency Treatment Market Share by End User Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2014-2019) (K Units) Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries Figure GCC Countries Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Turkey Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure Egypt Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units) Figure South Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales by Product (2014-2019) (K Units) Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Market Share by Product Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales by End User (2014-2019) (K Units) Table Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Market Share by End User Table Pfizer Company Details Table Pfizer Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Recent Development Table Baxter Company Details Table Baxter Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Baxter Recent Development Table AstraZeneca Company Details Table AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table AstraZeneca Recent Development Table Grifols Company Details Table Grifols Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Grifols Recent Development Table Teva Pharmaceutical Industries Company Details Table Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Teva Pharmaceutical Industries Recent Development Table Boehringer Ingelheim Company Details Table Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Boehringer Ingelheim Recent Development Table Kamada Ltd Company Details Table Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Kamada Ltd Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table GlaxoSmithKline Recent Development Table CSL Behring Company Details Table CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table CSL Behring Recent Development Table Shire Company Details Table Shire Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Shire Recent Development Table LFB Biomedicaments Company Details Table Abeona Therapeutics Company Details Table Biogen Company Details Table Applied Genetic Technologies Company Details Table Baxalta Company Details Table Arrowhead Research Corporation Company Details Table ProBioGen Company Details Table Chiesi Pharmaceuticals Company Details Table Curaxys Company Details Table ProMetic Life Sciences Company Details Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Regions 2019-2025 (K Units) Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share Forecast by Regions 2019-2025 Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share Forecast by Regions 2019-2025 Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Product 2019-2025 (K Units) Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share Forecast by Product 2019-2025 Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Forecast by Product 2019-2025 (Million US$) Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share Forecast by Product 2019-2025 Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by End User 2019-2025 (K Units) Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share Forecast by End User 2019-2025 Figure North America Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Alpha 1 Antitrypsin Deficiency Treatment Value Chain Table Alpha 1 Antitrypsin Deficiency Treatment Customers List Table Alpha 1 Antitrypsin Deficiency Treatment Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Get Free Sample

Related Reports

Global Alpha 1 Antitrypsin Deficiency Treatment Market Insights, Forecast to 2025

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Alpha 1 Antitrypsin Deficiency Treatment Market Insights, Forecast to 2025

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Alpha 1 Antitrypsin Deficiency Treatment Market Insights, Forecast to 2025

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Alpha 1 Antitrypsin Deficiency Treatment Market Insights, Forecast to 2025

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Alpha 1 Antitrypsin Deficiency Treatment Market Insights, Forecast to 2025

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)